Evaluation of the Epidemiological Effectiveness of a Quadrivalent Inactivated Split Influenza Vaccine in the 2023–2024 flu season

Evaluation of the Epidemiological Effectiveness of a Quadrivalent Inactivated Split Influenza Vaccine in the 2023–2024 flu season

Relevance. A distinctive feature of the influenza is the risk of severe complications, including cardiovascular (myocarditis or pericarditis) and nervous (encephalitis, meningoencephalitis and arachnoiditis) systems. Vaccination against influenza can significantly reduce the risk of disease, includi...

Full description

Saved in:
Bibliographic Details
Main Authors: R. V. Polibin, T. S. Saltykova, А. А. Pozdnyakov, V. A. Korshunov, A. G. Saltykova, N. I. Briko
Format: Article
Language:Russian
Published: Numikom LLC 2025-01-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
influenza
morbidity vaccination
ultrix quadri®
effectiveness
risk groups no conflict of interest to declare
Online Access:https://www.epidemvac.ru/jour/article/view/2126
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items